Quit Smoking | Shim Clinic, Singapore

Quit Smoking | Shim Clinic, Singapore: Quit/stop smoking with the medication varenicline (Champix®/Chantix®). Smoking cessation clinic, Singapore. Private and confidential service. Definitions, references, and latest news.

Description

Quit smoking with the medication varenicline (Champix® / Chantix®). Revolutionary new way to stop smoking at our smoking cessation clinic. Get away from the harmful effects of smoking, without feeling the effects of withdrawal!

Smoking cessation program cost:

References

• Quit Smoking images
• Quit Smoking - Wikipedia, the free encyclopedia
• Quit Smoking: Definition from Answers.com
• Quit Smoking - definition of Quit Smoking in the Medical dictionary - by the Free Online Medical Dictionary, Thesaurus and Encyclopedia.

Law Offices of James Scott Farrin Now Offering No Cost Case...
Thu, 28 Feb 2013 23:30:17 +0100 | PRWeb: Medical Pharmaceuticals
The North Carolina dangerous drugs lawyers at the Law Offices of James Scott Farrin are now offering free case evaluations to anyone who took Chantix and believe they suffered these or other serious...(PRWeb February 28, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10478539.htm (Source: PRWeb: Medical Pharmaceuticals)

Use of Varenicline vs Bupropion and Risk of Psychiatric Adverse Events
Thu, 28 Feb 2013 05:00:00 +0100 | Addiction
ConclusionsIn Denmark, the risk of psychiatric adverse events diagnosed during an emergency department visit or inpatient admission is not significantly higher with varenicline use compared with bupropion. (Source: Addiction)

Resisting the Urge to Smoke and Craving during a Smoking Quit Attempt on Varenicline: Results from a Pilot fMRI Study.
Wed, 27 Feb 2013 13:40:26 +0100 | The American Journal of Drug and Alcohol Abuse
Conclusion: Successful smoking cessation with varenicline is associated with increased activation, prior to a quit attempt, in brain areas related to attentiveness and memory while resisting the urge to smoke Scientific Significance: Varenicline may exert effects by both reducing craving and enhancing resistance to smoking urges during cue-elicited craving.

Effects of Varenicline on Ethanol‐ and Food‐Maintained Responding in a Concurrent Access Procedure
Fri, 15 Feb 2013 05:00:00 +0100 | Alcoholism: Clinical and Experimental Research
ConclusionsPrevious reports of varenicline selectivity on EtOH‐maintained responding do not generalize to other experimental conditions such as a concurrent schedule. The increase in responding for EtOH following lower doses might be due to enhanced EtOH reinforcement, decreased food reinforcement, rate dependency, or greater perseverance on the initial, EtOH response. (Source: Alcoholism: Clinical and Experimental Research)

Effects of Varenicline on Ethanol- and Food-Maintained Responding in a Concurrent Access Procedure.
Fri, 15 Feb 2013 05:00:00 +0100 | Alcoholism, Clinical and Experimental Research
CONCLUSIONS: Previous reports of varenicline selectivity on EtOH-maintained responding do not generalize to other experimental conditions such as a concurrent schedule. The increase in responding for EtOH following lower doses might be due to enhanced EtOH reinforcement, decreased food reinforcement, rate dependency, or greater perseverance on the initial, EtOH response.

Smokers Die About A Decade Earlier On Average
Wed, 30 Jan 2013 20:41:58 +0100 | WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire
WebMD Medical News

Varenicline in Autistic Disorder: Hypothesis and Case Report of Single-Patient Crossover
Sat, 26 Jan 2013 04:02:18 +0100 | Journal of Child and Adolescent Psychopharmacology
Journal of Child and Adolescent Psychopharmacology , Vol. 0, No. 0. (Source: Journal of Child and Adolescent Psychopharmacology)

Nicotine‐motivated behavior in Caenorhabditis elegans requires the nicotinic acetylcholine receptor subunits acr‐5 and acr‐15
Fri, 25 Jan 2013 05:00:00 +0100 | European Journal of Neuroscience
Abstract

CC4, a dimer of cytisine, is a selective partial agonist at α4β2/α6β2 nAChR with improved selectivity for tobacco smoking cessation
Thu, 24 Jan 2013 05:00:00 +0100 | British Journal of Pharmacology
Conclusion and ImplicationsOur in vitro and in vivo findings reveal that CC4 selectively reduces behaviours associated with nicotine addiction consistent with the partial agonist selectivity of CC4 for β2‐nAChRs. The results support the possible development of CC4 or its derivatives as a promising drug for tobacco smoking cessation. (Source: British Journal of Pharmacology)

More Than 40 States Get An ‘F’ For Tobacco Control
Thu, 17 Jan 2013 16:27:56 +0100 | WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire
WebMD Medical News

ABOUT TRUST ONLINE